These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 12519922

  • 21. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR.
    N Engl J Med; 1993 Feb 25; 328(8):527-32. PubMed ID: 8426619
    [Abstract] [Full Text] [Related]

  • 22. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.
    Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE.
    Int J Tuberc Lung Dis; 2003 Jul 25; 7(7):637-44. PubMed ID: 12870684
    [Abstract] [Full Text] [Related]

  • 23. Retreatment management strategies when first-line tuberculosis therapy fails.
    Saravia JC, Appleton SC, Rich ML, Sarria tM, Bayona J, Becerra MC.
    Int J Tuberc Lung Dis; 2005 Apr 25; 9(4):421-9. PubMed ID: 15830748
    [Abstract] [Full Text] [Related]

  • 24. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru.
    Somocurcio JG, Sotomayor A, Shin S, Portilla S, Valcarcel M, Guerra D, Furin J.
    Thorax; 2007 May 25; 62(5):416-21. PubMed ID: 16928717
    [Abstract] [Full Text] [Related]

  • 25. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S.
    Clin Infect Dis; 2010 Jan 01; 50(1):49-55. PubMed ID: 19947856
    [Abstract] [Full Text] [Related]

  • 26. Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.
    Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, Tan Torres T, Ong M, Barez MY, Ang CF.
    Int J Tuberc Lung Dis; 1997 Feb 01; 1(1):59-63. PubMed ID: 9441060
    [Abstract] [Full Text] [Related]

  • 27. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC, Salomon JA, Murray M, Weinstein MC.
    PLoS Med; 2006 Jul 01; 3(7):e241. PubMed ID: 16796403
    [Abstract] [Full Text] [Related]

  • 28. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
    Shin SS, Hyson AM, Castañeda C, Sánchez E, Alcántara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ.
    Int J Tuberc Lung Dis; 2003 Apr 01; 7(4):347-53. PubMed ID: 12729340
    [Abstract] [Full Text] [Related]

  • 29. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS.
    Ann Afr Med; 2010 Apr 01; 9(1):15-9. PubMed ID: 20418644
    [Abstract] [Full Text] [Related]

  • 30. The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB).
    Palacios E, Guerra D, Llaro K, Chalco K, Sapag R, Furin J.
    Int J Tuberc Lung Dis; 2003 Apr 01; 7(4):343-6. PubMed ID: 12729339
    [Abstract] [Full Text] [Related]

  • 31. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.
    Clin Infect Dis; 2007 Nov 15; 45(10):1290-5. PubMed ID: 17968823
    [Abstract] [Full Text] [Related]

  • 32. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.
    Kekkaku; 2007 Feb 15; 82(2):95-101. PubMed ID: 17373318
    [Abstract] [Full Text] [Related]

  • 33. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis.
    Lockman S, Kruuner A, Binkin N, Levina K, Wang Y, Danilovitsh M, Hoffner S, Tappero J.
    Clin Infect Dis; 2001 Feb 01; 32(3):373-80. PubMed ID: 11170944
    [Abstract] [Full Text] [Related]

  • 34. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K.
    Kekkaku; 1998 Jul 01; 73(7):471-6. PubMed ID: 9739579
    [Abstract] [Full Text] [Related]

  • 35. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec 01; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 36. Outcomes of individualised treatment for multidrug-resistant tuberculosis before DOTS-plus.
    Ollé-Goig JE, Sandy R.
    Int J Tuberc Lung Dis; 2005 Jul 01; 9(7):765-70. PubMed ID: 16013772
    [Abstract] [Full Text] [Related]

  • 37. Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic.
    Rodriguez M, Monedero I, Caminero JA, Encarnación M, Dominguez Y, Acosta I, Muñoz E, Camilo E, Martinez-Selmo S, de los Santos S, del Granado M, Casals M, Cayla J, Marcelino B.
    Int J Tuberc Lung Dis; 2013 Apr 01; 17(4):520-5. PubMed ID: 23485386
    [Abstract] [Full Text] [Related]

  • 38. Contact investigations as a means of detection and timely treatment of persons with infectious multidrug-resistant tuberculosis.
    Bayona J, Chavez-Pachas AM, Palacios E, Llaro K, Sapag R, Becerra MC.
    Int J Tuberc Lung Dis; 2003 Dec 01; 7(12 Suppl 3):S501-9. PubMed ID: 14677844
    [Abstract] [Full Text] [Related]

  • 39. [Miss-management in treatment failure of pulmonary tuberculosis].
    Ito K, Yoshiyama T, Wada M, Ogata H.
    Kekkaku; 2004 Oct 01; 79(10):561-7. PubMed ID: 15631107
    [Abstract] [Full Text] [Related]

  • 40. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB.
    Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS.
    Int J Tuberc Lung Dis; 2006 Mar 01; 10(3):290-6. PubMed ID: 16562709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.